These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 3774198)
1. [Blood chemical parameters in the monitoring of inoperable bronchogenic carcinoma]. Barberis S; Ciotta D; Fusaro E; Galietti F; Giorgis GE; Oliaro A; Scappaticci E Minerva Med; 1986 Oct; 77(39):1789-92. PubMed ID: 3774198 [TBL] [Abstract][Full Text] [Related]
2. [The significance of tumor-associated antigens in the diagnosis and therapeutic control of bronchial cancer]. Gropp C; Luster W; Havemann K Prax Klin Pneumol; 1982 Dec; 36(12):491-9. PubMed ID: 7163127 [No Abstract] [Full Text] [Related]
3. Clinical usefulness of serum ferritin measurements in lung cancer patients. Volpino P; Cangemi V; Caputo V; Mazzarino E; Galati G J Nucl Med Allied Sci; 1984; 28(1):27-30. PubMed ID: 6481468 [No Abstract] [Full Text] [Related]
4. [Serum carbohydrate 19-9 Tm and bronchial cancer. Comparative study with another tumor marker, carcinoembryonic antigen]. Bisset JP; Kleisbauer JP; Roux F; Treffot MJ Pathol Biol (Paris); 1985 Jun; 33(6):672-6. PubMed ID: 3900886 [TBL] [Abstract][Full Text] [Related]
5. Multiple sequential biomarkers in monitoring patients with carcinoma of the lung. Aroney RS; Dermody WC; Aldenderfer P; Parsons P; McNitt K; Marangos PJ; Whitacre MY; Ruddon RW; Wiernik PH; Aisner J Cancer Treat Rep; 1984 Jun; 68(6):859-66. PubMed ID: 6329508 [TBL] [Abstract][Full Text] [Related]
7. [Serum levels of CEA and ferritin in lung cancer before, during and after radiotherapy]. Tatsuno I; Konishi K Rinsho Hoshasen; 1983 Nov; 28(12):1487-90. PubMed ID: 6323796 [No Abstract] [Full Text] [Related]
8. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study. Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259 [TBL] [Abstract][Full Text] [Related]
9. [Value of tumor markers in surveillance of primary bronchial cancers and to evaluate therapy]. Sculier JP Rev Mal Respir; 1997 Apr; 14 Suppl 3():S23-6. PubMed ID: 9229744 [No Abstract] [Full Text] [Related]
10. [The importance of measuring plasma carcinoembryonic antigen in small-cell anaplastic carcinoma]. Michetti G; Bamberga M; Pugliese C; Ori Belometti M; Arnone P; Minio A; Ciaravino G; Villa R; Alesina R; Cottini M Minerva Med; 1994 May; 85(5):231-6. PubMed ID: 8028751 [TBL] [Abstract][Full Text] [Related]
11. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer. Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326 [TBL] [Abstract][Full Text] [Related]
12. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer]. Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042 [TBL] [Abstract][Full Text] [Related]
14. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer. Milman N; Pedersen LM Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482 [TBL] [Abstract][Full Text] [Related]
15. [Association of serum tumor markers in solid neoplasms (CEA, ferritin, alpha 1-antitrypsin, parathormone and calcitonin)]. Di Martino G; Iannucci F; Bizzarro A; Iacono G Boll Ist Sieroter Milan; 1982; 61(5):411-22. PubMed ID: 6985416 [TBL] [Abstract][Full Text] [Related]
16. [Usefulness of measuring serum ferritin in the diagnosis and staging of non-microcytoma bronchial carcinoma]. Rapellino M; Baldi S; Obert R; Pecchio F; Oliaro A; Mancuso M Minerva Med; 1986 Dec; 77(47-48):2221-2. PubMed ID: 3808380 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580 [TBL] [Abstract][Full Text] [Related]
18. Tissue polypeptide antigen in bronchogenic carcinoma. Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159 [TBL] [Abstract][Full Text] [Related]
19. Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis. Matsuguma H; Nakahara R; Igarashi S; Ishikawa Y; Suzuki H; Miyazawa N; Honjo S; Yokoi K J Thorac Cardiovasc Surg; 2008 Jan; 135(1):44-9. PubMed ID: 18179917 [TBL] [Abstract][Full Text] [Related]
20. [Value of monitoring serum carcinoembryonic antigen (CEA) levels for prognosis of patients with lung cancer treated by non-surgical methods]. Ochnio J; Rogińska E; Kwiek S; Rowińska-Zakrzewska E Pneumonol Pol; 1984 Jul; 52(7):321-9. PubMed ID: 6093066 [No Abstract] [Full Text] [Related] [Next] [New Search]